BRCA1 and breast carcinoma: XZP-7797 also showed good PK and ADME properties and good BBB penetration in a mouse model and demonstrated significant efficacy in breast cancer cell lines, a BRCA1-mutated breast cancer CDX model, and a pancreatic cancer CDX model [115].